InvestorsHub Logo
Followers 467
Posts 26931
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 6270

Tuesday, 11/13/2012 9:47:45 AM

Tuesday, November 13, 2012 9:47:45 AM

Post# of 6488
8:07AM Insmed announces CLEAR-108 Phase 3 clinical study of ARIKACE in cystic fibrosis patients with pseudomonas lung infections has completed target enrollment (INSM) 6.98 : Co states: "The completion of enrollment in this pivotal phase 3 clinical trial represents an important milestone for Insmed as we advance ARIKACE closer to commercialization. We continue to expect top-line data from CLEAR-108 to be available in mid-2013."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INSM News